Insider Ownership Details

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.

Name Shares Options
Novartis Institutes for BioMedical Research, Inc. 4,129,903 0
Caribou Biosciences, Inc. 3,994,355 0
Atlas Venture Fund IX, L.P. 3,579,788 0
GORDON CARL L 2,662,180 19,000
ORBIMED ADVISORS LLC 2,662,180 0
BAKER BROS. ADVISORS LP 976,214 0
Temasek Holdings (Private) Ltd 790,527 0
LEONARD JOHN M. 766,825 0
FORMELA JEAN FRANCOIS 1See Footnote 563,376 0
Bermingham Nessan 458,250 292,500
Rivera Jose E 162,388 6,116
BASTA JAMES 55,279 0
Clark Eliana 45,146 0
Lebwohl David 25,687 0
Sepp-Lorenzino Laura 17,629 0
Hicks Derek 17,306 0
SCHIERMEIER ANDREW 16,656 78,750
Goddard Glenn 15,404 0
Bhanji Muna 12,261 0
FORMELA JEAN FRANCOIS 10,000 0
DORSA CAROLINE 5,410 3,382
KARSEN PERRY A 5,000 0
Crowley John F 2,094 25,500
Keresty Georgia 0 2,534
Bell Graeme 0 25,000
Temasek Holdings (Private) Ltd Held by TLS Beta Pte. Ltd. 0 0
Temasek Holdings (Private) Ltd Held by TLS Beta Pte. Ltd 0 0
CHASE WILLIAM J 0 0
Heifner Nicole 0 28,500
GOODMAN JESSE 0 3,382
Verwiel Frank 0 3,382
Atlas Venture Associates IX, L.P. 0 0
Haurwitz Rachel E. 0 23,529
Morrissey David V 0 30,000
Barnes Thomas M. 0 50,500
Slaoui Moncef 0 38,000
Caribou Therapeutics Holdco, LLC 0 0
0 0
Cohen Fred E 0 3,382
Srivastava Sapna 0 0
 

While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price

Recent Insider Sales

Name Shares Price Date
Bhanji Muna 265 42.33 2023 Jul 31
Bhanji Muna 1,867 39.30 2023 Jul 06
Clark Eliana 360 40.51 2023 Jul 03
Clark Eliana 5,000 45.00 2023 Jun 20
 

Recent Insider Purchases

Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.

Name Shares Price Date